Burkitt lymphoma in the setting of common variable immunodeficiency

Annals of Hematology

Volumn 88, Issue 8, 2009, Pages 819-820

  Polizzotto, Mark N ^a   McComish, Jeremy S ^a   Dawson, Mark A ^a   Opat, Stephen S ^a   Cole Sinclair, Merrole F ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; IFOSFAMIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; KI 67 ANTIGEN; METHOTREXATE; PROTEIN BCL 6; RASBURICASE; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADULT; BONE MARROW BIOPSY; BRONCHIECTASIS; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DRUG MEGADOSE; FEVER; GASTROINTESTINAL INFECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; IMMUNOHISTOCHEMISTRY; LETTER; LEUKOCYTE COUNT; LUNG FUNCTION; LUNG INFECTION; MALE; OSTEOPOROSIS; PARESTHESIA; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; THROMBOCYTE COUNT; TUMOR CELL DESTRUCTION; WEIGHT REDUCTION;

BURKITT LYMPHOMA; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MANDIBULAR DISEASES; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 67649395582     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0691-5     Document Type: Letter

References (10)

1. Wehr C, Kivioja T, Schmitt C et al (2008) The EUROClass trial: Defining subgroups in common variable immune deficiency. Blood 111:77-85, doi: 10.1182/blood-2007-06-091744
2. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P (1987) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294-299, doi: 10.1007/BF00915550
3. Chua I, Quinti I, Grimbacher B (2008) Lymphoma in common variable immunodeficiency: Interplay between immune dysregulation, infection and genetics. Curr Opin Hematol 15:368-374, doi: 10.1097/MOH.0b013e328302c7b6
4. Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104:3009-3020, doi: 10.1182/blood-2004-02-0405
5. Lombardi L, Newcomb EW, Dalla-Favera R (1987) Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49:161-170, doi: 10.1016/0092-8674(87)90556-3
6. Mead GM, Sydes MR, Walewski J (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13:1264-1274, doi: 10.1093/annonc/mdf253
7. Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Clin Immunol 93:190-197 (Current version at www.esid.org, accessed 1 November 2008)
8. Taubenheim N, von Hornung M, Durandy A et al (2005) Defined blocks of terminal plasma cell differentiation of common variable immunodeficiency patients. J Immunol 175:5498-5503
9. Nichols K, Ma CS, Cannons JL et al (2005) Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 203:180-199, doi: 10.1111/j.0105-2896.2005.00230.x
10. Quinti I, Soresina A, Spadaro G et al (2007) Long term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 27:308-316, doi: 10.1007/ s10875-007-9075-1